Nexpoint Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Nexpoint Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-198,278	Closed	-$7.47M	–	240
2021 Q1	$7.47M	Buy	+198,278	New	+$4.94M	1.95%	14

Nexpoint Asset Management's FPRX Position: Q2 2021 in Review

Nexpoint Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 198,278 shares — an estimated $7.47M sold.

Nexpoint Asset Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $7.47M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Nexpoint Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Nexpoint Asset Management sold 198,278 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $7.47M.
Nexpoint Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Nexpoint Asset Management's Five Prime Therapeutics, Inc. position peaked at $7.47M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Nexpoint Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.